Gopal Deepak V, Lieberman David A, Magaret Nathan, Fennerty M Brian, Sampliner Richard E, Garewal Harinder S, Falk Gary W, Faigel Douglas O
Oregon Health & Science University and Portland VA Medical Center, Portland, Oregon, USA.
Dig Dis Sci. 2003 Aug;48(8):1537-41. doi: 10.1023/a:1024715824149.
Studies show Barrett's esophagus prevalence increases with age, while mean length of Barrett's esophagus is unchanged. Few data are available about the relationship between age and length on the development of dysplasia. Our aim was to assess age and length as risk factors for dysplasia. Consecutive patients with Barrett's esophagus were enrolled in a multicenter study establishing a tissue bank of Barrett's esophagus patients 1994 and 1998. Demographics, length of Barrett's esophagus (centimeters), and histology were recorded. Risk factors for dysplasia were assessed, including patient age, gender, and length of Barrett's esophagus. Statistical analysis was performed comparing prevalence of dysplasia (which included the presence of any carcinoma and high- or low-grade dysplasia) to age and length. In all, 309 patients were studied [278 (90%) male and 31 (10%) female]: 5 had adenocarcinoma of the esophagus, 11 had high-grade dysplasia, and 29 had low-grade dysplasia. Patients with Barrett's esophagus without dysplasia were younger than those with dysplasia [62 +/- 0.8 years vs 67 +/- 1.7 years (mean +/- SEM, P = 0.02)]. The risk of dysplasia increased by 3.3%/yr of age. Mean length of Barrett's esophagus in patients with Barrett's alone vs dysplasia was 4.0 +/- 0.2 cm vs 5.4 +/- 0.4 cm (P = 0.003). Patients with Barrett's esophagus length > or = 3 cm had a significantly greater prevalence of dysplasia compared to length < 3 cm (23% vs 9%, P = 0.0001). The risk of dysplasia increased by 14%/cm of increased length. Multivariate analysis showed age and length to be independent risk factors. In conclusions: prevalence of dysplasia is strongly associated with age and length of Barrett's esophagus. These preliminary results can be used to develop a strategy for screening/surveillance based on age and length of Barrett's epithelium.
研究表明,巴雷特食管的患病率随年龄增长而增加,而巴雷特食管的平均长度保持不变。关于年龄与长度在发育异常发生中的关系,现有数据较少。我们的目的是评估年龄和长度作为发育异常的风险因素。1994年至1998年,连续的巴雷特食管患者被纳入一项多中心研究,该研究建立了一个巴雷特食管患者组织库。记录了人口统计学数据、巴雷特食管的长度(厘米)和组织学情况。评估了发育异常的风险因素,包括患者年龄、性别和巴雷特食管的长度。进行了统计分析,比较发育异常(包括任何癌以及高级别或低级别发育异常)的患病率与年龄和长度的关系。总共研究了309例患者[278例(90%)男性和31例(10%)女性]:5例患有食管腺癌,11例患有高级别发育异常,29例患有低级别发育异常。无发育异常的巴雷特食管患者比有发育异常的患者更年轻[62±0.8岁对67±1.7岁(平均值±标准误,P = 0.02)]。发育异常的风险每年增加3.3%。单纯巴雷特食管患者与有发育异常患者的巴雷特食管平均长度分别为4.0±0.2厘米和5.4±0.4厘米(P = 0.003)。与长度<3厘米相比,巴雷特食管长度≥3厘米的患者发育异常的患病率显著更高(23%对9%,P = 0.0001)。长度每增加1厘米,发育异常的风险增加14%。多变量分析显示年龄和长度是独立的风险因素。结论:发育异常的患病率与巴雷特食管的年龄和长度密切相关。这些初步结果可用于制定基于巴雷特上皮的年龄和长度的筛查/监测策略。